Civeo Corp (CVEO) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on December 4, 2019, reporting an event that occurred on November 27, 2019. Civeo Corporation, a company incorporated in British Columbia, Canada, operates with principal executive offices in Houston, Texas. The filing addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the listing status of its common shares.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the regulatory notice:
- Average Closing Price: Below $1.00 per share over a 30 consecutive trading day period.
- Minimum Requirement: $1.00 per share average closing price to maintain NYSE listing under Section 802.01C.
Material Changes and Events
The primary material event is the receipt of a notice of noncompliance from the NYSE due to the low average closing price of the Company's common shares. Consequently:
- The stock will trade with a ".BC" designation to indicate "below compliance" status.
- The shares remain listed and tradable on the NYSE during the cure period.
- The Company has a six-month period to regain compliance.
Outlook, Management Commentary, and Risks
Management Plan: The Company has notified the NYSE of its intent to cure the deficiency. The Board of Directors intends to propose a reverse share split for shareholder approval at the annual meeting scheduled for May 2020.
Risks and Contingencies: If the Company fails to regain compliance, the NYSE may initiate delisting procedures. Potential negative impacts of delisting include:
- Reduced liquidity and market price of common shares.
- Fewer investors willing to hold or acquire shares, hindering equity financing.
- Limited ability to use registration statements to offer freely tradable securities.
- Impaired ability to provide equity incentives to employees.
Key Facts for Investor Verification
- Verify the current trading price and volume of CVEO shares to assess the likelihood of meeting the $1.00 average closing price requirement without a reverse split.
- Monitor the Company's progress toward the May 2020 annual meeting for shareholder approval of the proposed reverse share split.
- Review the press release dated December 4, 2019 (Exhibit 99.1) for additional details on the noncompliance notice.
- Assess the impact of the ".BC" trading designation on institutional investor mandates that may restrict trading of non-compliant securities.